To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip Arthroplasty

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 26, 2025

Primary Completion Date

November 20, 2025

Study Completion Date

December 27, 2025

Conditions
Postoperative Analgesia After Unilateral Hip Arthroplasty
Interventions
DRUG

TRD205 tablets

Administered orally every 12 hours for a total of four times;Take TRD205 2 tablets and Placebo 4 tablets for the first time ,TRD205 1 tablets and Placebo 2 tablets each for the other three times

DRUG

TRD205 tablets

Administered orally every 12 hours for a total of four times;Take TRD205 4 tablets and Placebo 2 tablets for the first time ,TRD205 2 tablets and Placebo 1 tablets each for the other three times.

DRUG

TRD205 tablets

Administered orally every 12 hours for a total of four times;Take TRD205 6 tablets and Placebo 0 tablets for the first time ,TRD205 3 tablets and Placebo 0 tablets each for the other three times.

DRUG

placebo

Administered orally every 12 hours for a total of four times;Take Placebo 6 tablets for the first time ,Placebo 3 tablets each for the other three times.

Trial Locations (1)

Unknown

The Third Affiliated Hospital of Southern Medical University, Guangzhou

All Listed Sponsors
collaborator

The Third Affiliated Hospital of Southern Medical University

OTHER_GOV

lead

Beijing Tide Pharmaceutical Co., Ltd

INDUSTRY